Science Explorer Interactive view Map
Company · Cambridge · ??

FogPharma (United States)

fogpharma.comROR OpenAlex
Research works
2
▲ 23% vs 2013–17
Citations
247
102.9 per fractional work
Top-10% rate
13.7%
record average 16.5%
Open access
78%
world 28%

Not ranked overall: FogPharma (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which research topics does FogPharma (United States) publish most on?

By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, Chemical Synthesis and Analysis, Glycosylation and Glycoproteins Research and Protein purification and stability.

Monoclonal and Polyclona…0Monoclonal and Polyclonal Antibodies Research: 0 fractional worksChemical Synthesis and A…0Chemical Synthesis and Analysis: 0 fractional worksGlycosylation and Glycop…0Glycosylation and Glycoproteins Research: 0 fractional worksProtein purification and stability: 0 fractional works
Radiology, Nuclear Medicine and ImagingMolecular Biology

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  2. 2 Chemical Synthesis and Analysis Molecular Biology 0 works
  3. 3 Glycosylation and Glycoproteins Research Molecular Biology 0 works
  4. 4 Protein purification and stability Molecular Biology 0 works
  5. 5 Protein Structure and Dynamics Molecular Biology 0 works
  6. 6 RNA and protein synthesis mechanisms Molecular Biology 0 works
  7. 7 Protein Degradation and Inhibitors Molecular Biology 0 works
  8. 8 Metabolomics and Mass Spectrometry Studies Molecular Biology 0 works
  9. 9 Scientific Computing and Data Management Information Systems and Management 0 works
  10. 10 Ubiquitin and proteasome pathways Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available78.5%not open21.5%

World: 28% of research is openly available.

with international co-authors53.4%domestic only46.6%

World: 19% is written across borders.

How has FogPharma (United States)'s research output changed?

Output in 2018–2022 was 23% higher than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Cambridge

All research institutions in Cambridge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.